Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. World most cancers statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 nations, CA: a most cancers journal for clinicians 74(2024):229–63.
Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, Dhanjal JK, Dewanjee S, Vallamkondu J. Pérez de La lastra, Most cancers chemotherapy and past: present standing, drug candidates, related dangers and progress in focused therapeutics. Genes Dis. 2023;10:1367–401.
Advancing Most cancers Remedy. Nat Most cancers. 2021;2:245–6.
The worldwide problem of most cancers. Nat Most cancers. 2020;1:1–2.
Tohme S, Simmons RL, Tsung A. Surgical procedure for most cancers: A set off for metastases. Most cancers Res. 2017;77:1548–52.
World variation in. Postoperative mortality and issues after most cancers surgical procedure: a multicentre, potential cohort examine in 82 nations. Lancet (London England). 2021;397:387–97.
Chen HHW, Kuo MT. Enhancing radiotherapy in most cancers therapy: guarantees and challenges. Oncotarget. 2017;8:62742–58.
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T. New approaches and procedures for most cancers therapy: present views. SAGE Open Med. 2021;9:20503121211034366.
Correia JH, Rodrigues JA, Pimenta S, Dong T, Yang Z. Photodynamic remedy evaluation: ideas, photosensitizers, purposes, and future instructions. Pharmaceutics 13 (2021).
Agostinis P, Berg Okay, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic remedy of most cancers: an replace. Most cancers J Clin. 2011;61:250–81.
Calixto GM, Bernegossi J, de Freitas LM, Fontana CR, Chorilli M. Nanotechnology-Based mostly drug supply methods for photodynamic remedy of most cancers: A evaluation. Molecules. 2016;21:342.
Xu PY, Kumar Kankala R, Wang SB, Chen AZ. Sonodynamic therapy-based nanoplatforms for combating bacterial infections. Ultrason Sonochem. 2023;100:106617.
Pan X, Wang H, Wang S, Solar X, Wang L, Wang W, Shen H, Liu H. Sonodynamic remedy (SDT): a novel technique for most cancers nanotheranostics. Sci China Life Sci. 2018;61:415–26.
Choi V, Rajora MA, Zheng G. Activating medicine with sound: mechanisms behind sonodynamic remedy and the function of nanomedicine. Bioconjug Chem. 2020;31:967–89.
Ouyang J, Tang Z, Farokhzad N, Kong N, Kim NY, Feng C, Blake S, Xiao Y, Liu C, Xie T, Tao W. Ultrasound mediated remedy: current progress and challenges in nanoscience. Nano Immediately. 2020;35:100949.
Wu P, Wang X, Lin W, Bai L. Acoustic characterization of cavitation depth: A evaluation. Ultrason Sonochem. 2022;82:105878.
Casacchia A, George P, Wilson P, Hamilton M. Analysis of a possible medical prognosis utility of sonoluminescence. J Acoust Soc Am. 2019;145:1811–1811.
Zhou Z, Li B, Liu X, Li Z, Zhu S, Liang Y, Cui Z, Wu S. Latest progress in photocatalytic antibacterial. ACS Appl Bio Mater. 2021;4:3909–36.
Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, Murphy MP, Yamamoto M, Winterbourn C. Defining roles of particular reactive oxygen species (ROS) in cell biology and physiology, nature critiques. Mol Cell Biology. 2022;23:499–515.
Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling brokers, nature critiques. Mol Cell Biology. 2020;21:363–83.
Hong Y, Boiti A, Vallone D, Foulkes NS. Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution. Antioxid (Basel Switzerland) 13 (2024).
Juan CA, Pérez de la Lastra JM, Plou FJ, Pérez-Lebeña E. The chemistry of reactive oxygen species (ROS) revisited: outlining their function in organic macromolecules (DNA, lipids and Proteins) and induced pathologies. Int J Mol Sci 22 (2021).
Zhao X, Liu Q, Tang W, Wang X, Wang P, Gong L, Wang Y. Harm results of protoporphyrin IX – sonodynamic remedy on the cytoskeletal F-actin of Ehrlich Ascites carcinoma cells. Ultrason Sonochem. 2009;16:50–6.
Weinberg F, Ramnath N, Nagrath D. Reactive oxygen species within the tumor microenvironment: an outline. Cancers 11 (2019).
Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative Stress Most cancers Most cancers Cell. 2020;38:167–97.
Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of Immunogenic cell demise and its relevance for most cancers remedy. Cell Demise Dis. 2020;11:1013.
Nowak KM, Schwartz MR, Breza VR, Value RJ. Sonodynamic remedy: fast progress and new alternatives for non-invasive tumor cell killing with sound. Most cancers Lett. 2022;532:215592.
Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell demise and damps in most cancers remedy. Nat Rev Most cancers. 2012;12:860–75.
Wang N, Luo L, Xu X, Zhou H, Li F. Targeted ultrasound-induced cell apoptosis for the therapy of tumours. PeerJ 12 (2024).
Li D, Yang Y, Li DF, Pan J, Chu CC, Liu G. Natural sonosensitizers for sonodynamic remedy: from small molecules and nanoparticles towards medical improvement, small (Weinheim an der Bergstrasse. Germany) 17 (2021).
Xing XJ, Zhao SJ, Xu T, Huang L, Zhang Y, Lan MH, Lin CW, Zheng XL, Wang PF. Advances and views in natural sonosensitizers for sonodynamic remedy. Coord Chem Rev 445 (2021).
Jiang Z, Xiao W, Fu Q. Stimuli responsive nanosonosensitizers for sonodynamic remedy. J Managed Launch: Official J Managed Launch Soc. 2023;361:547–67.
Gong Z, Dai Z. Design and challenges of sonodynamic remedy system for Most cancers theranostics: from gear to sensitizers. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2021;8:2002178.
Yumita N, Nishigaki R, Umemura Okay, Umemura S. Hematoporphyrin as a sensitizer of cell-damaging impact of ultrasound. Japanese J most cancers Analysis: Gann. 1989;80:219–22.
Umemura S, Yumita N, Nishigaki R. Enhancement of ultrasonically induced cell harm by a gallium-porphyrin advanced, ATX-70. Japanese J most cancers Analysis: Gann. 1993;84:582–8.
Kou J, Dou D, Yang L. Porphyrin photosensitizers in photodynamic remedy and its purposes. Oncotarget. 2017;8:81591–603.
Yang F, Xu M, Chen X, Luo Y. Highlight on porphyrins: classifications, mechanisms and medical purposes. Biomed Pharmacother. 2023;164:114933.
Liao S, Cai M, Zhu R, Fu T, Du Y, Kong J, Zhang Y, Qu C, Dong X, Ni J, Yin X. Antitumor impact of photodynamic remedy/sonodynamic remedy/Sono-Photodynamic remedy of Chlorin e6 and different purposes. Mol Pharm. 2023;20:875–85.
Wu T, Liu Y, Cao Y, Liu Z. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic remedy of glioblastoma, superior supplies (Deerfield seaside. Fla). 2022;34:e2110364.
Xing X, Zhao S, Xu T, Huang L, Zhang Y, Lan M, Lin C, Zheng X, Wang P. Advances and views in natural sonosensitizers for sonodynamic remedy. Coord Chem Rev. 2021;445:214087.
Chen P, Zhang P, Shah NH, Cui Y, Wang Y. A complete evaluation of inorganic sonosensitizers for sonodynamic remedy. Int J Mol Sci 24 (2023).
Zlotver I, Shechtman N, Sosnik A. Hybrid amorphous titanium dioxide/polymeric nano-sonosensitizers in direction of the actively focused sonodynamic remedy of mind most cancers. J Colloid Interface Sci. 2025;694:137702.
Liu Y, Yang G, Jin S, Xu L, Zhao C-X. Improvement of Excessive-Drug‐Loading Nanoparticles, ChemPlusChem 85 (2020).
Zhang H, Chen J, Zhu X, Ren Y, Cao F, Zhu L, Hou L, Zhang H, Zhang Z. Ultrasound induced phase-transition and invisible nanobomb for imaging-guided tumor sonodynamic remedy. J Mater Chem B. 2018;6:6108–21.
Basha SS, Babunagappan KV, Kabir A, Raj T, Sudhakar S. Microgravity as a platform to reinforce drug loading effectivity in nanomaterials. J Drug Deliv Sci Technol. 2024;98:105869.
Yang SW, Wang XL, He P, Xu AL, Wang G, Duan JL, Shi YQ, Ding GQ. Graphene quantum Dots with pyrrole N and pyridine N: superior reactive oxygen species era effectivity for Metallic-Free sonodynamic tumor remedy, small (Weinheim an der Bergstrasse. Germany) 17 (2021).
Li C, Yang XQ, An J, Cheng Okay, Hou XL, Zhang XS, Hu YG, Liu B, Zhao YD. Crimson blood cell membrane-enveloped O(2) self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic remedy. Theranostics. 2020;10:867–79.
Liang S, Deng XR, Xu GY, Xiao X, Wang MF, Guo XS, Ma PA, Cheng ZY, Zhang D, Lin J. A novel Pt-TiO < sub > 2 Heterostructure with Oxygen-Poor layer as bilaterally enhanced sonosensitizer for synergistic Chemo-Sonodynamic Most cancers remedy. Adv Funct Mater 30 (2020).
Deepagan VG, You DG, Um W, Ko H, Kwon S, Choi KY, Yi GR, Lee JY, Lee DS, Kim Okay, Kwon IC, Park JH. Lengthy-Circulating Au-TiO < sub > 2 Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Most cancers, Nano letters 16 (2016) 6257–6264.
Solar WJ, Dong XJ, Huang PP, Shan J, Qi L, Zhou J. Solvothermal synthesis of Nb-doped tio < sub > 2 nanoparticles with enhanced sonodynamic results for destroying tumors. RSC Adv. 2021;11:36920–7.
Guo WH, Wang T, Huang CY, Ning SP, Guo QL, Zhang W, Yang HW, Zhu DM, Huang QQ, Qian HS, Wang XW. Platelet membrane-coated C-TiO < sub > 2 hole nanospheres for mixed sonodynamic and alkyl-radical most cancers remedy. Nano Res. 2023;16:782–91.
Li Y, Li W, Liu Y, Liu J, Yuan X, Zhang J, Shen H. Defect-rich platinum-zinc oxide heterojunction as a potent ROS amplifier for synergistic sono-catalytic remedy. Acta Biomater. 2023;171:543–52.
Wang F, Wang B, You W, Chen G, You YZ. Integrating Au and ZnO nanoparticles onto graphene nanosheet for enhanced sonodynamic remedy. Nano Res. 2022;15:9223–33.
Liu Y, Wang Y, Zhen W, Wang Y, Zhang S, Zhao Y, Tune S, Wu Z, Zhang H. Defect modified zinc oxide with augmenting sonodynamic reactive oxygen species era. Biomaterials. 2020;251:120075.
Pan X, Huang Z, Guo J, Wu Q, Wang C, Zhang H, Zhang J, Liu H. MOF-Derived nanoparticles with enhanced acoustical efficiency for environment friendly Mechano-Sonodynamic remedy, superior supplies (Deerfield seaside. Fla). 2024;36:e2400142.
Cheng M, Liu Y, You Q, Lei Z, Ji J, Zhang F, Dong WF, Li L. Metallic-Doping technique for Carbon-Based mostly sonosensitizer in sonodynamic remedy of glioblastoma. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2024;11:e2404230.
Gong F, Cheng L, Yang NL, Betzer O, Feng LZ, Zhou Q, Li YG, Chen RH, Popovtzer R, Liu Z. Ultrasmall Oxygen-Poor Bimetallic Oxide MnWO iX Nanoparticles for Depletion of Endogenous GSH and Enhanced Sonodynamic Most cancers Remedy, Superior Supplies 31 (2019)
Hu GY, Wang JR, Chen LL, Zheng HQ, Lan YP, Wang KY, Liu XJ, You HP, Luo Y, Dong LL. Small-Bandgap transducers induced provider separation for in situ Twin-Amplified tumor oxidative stress. Adv Funct Mater 34 (2024).
Zhu Y, Wang D, Du C, Wu T, Wei P, Zheng H, Li G, Zheng S, Su L, Yan L, Hu Y, Wang H, Lin L, Ding C, Chen X. Ruthenium Single-Atom nanozyme pushed sonosensitizer with oxygen vacancies enhances Electron-Gap separation efficacy and remodels tumor microenvironment for Sonodynamic-Amplified ferroptosis. Adv Sci (Weinh). 2025. e2416997.
Wang W, Wang P, Tang X, Elzatahry AA, Wang S, Al-Dahyan D, Zhao M, Yao C, Hung CT, Zhu X, Zhao T, Li X, Zhang F, Zhao D. Facile synthesis of uniform Virus-like mesoporous silica nanoparticles for enhanced mobile internalization. ACS Cent Sci. 2017;3:839–46.
Yang FF, Dong J, Li ZF, Wang ZH. Metallic-Natural frameworks (MOF)-Assisted sonodynamic remedy in anticancer purposes. ACS Nano. 2023;17:4102–33.
Liao DH, Huang JF, Jiang CY, Zhou LY, Zheng MB, Nezamzadeh-Ejhieh A, Qi N, Lu CY, Liu JQ. A Novel Platform of MOF for Sonodynamic Remedy Superior Therapies, Pharmaceutics 15 (2023).
Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species, biochimica et biophysica acta (BBA) -. Mol Cell Res. 2016;1863:2977–92.
Halliwell B. Free radicals and antioxidants– quo vadis? Traits Pharmacol Sci. 2011;32:125–30.
Nguyen Cao TG, Truong Hoang Q, Hong EJ, Kang SJ, Kang JH, Ravichandran V, Kang HC, Ko YT, Rhee WJ, Shim MS. Mitochondria-targeting sonosensitizer-loaded extracellular vesicles for chemo-sonodynamic remedy. J Managed Launch: Official J Managed Launch Soc. 2023;354:651–63.
Nguyen Cao TG, Truong Hoang Q, Kang JH, Kang SJ, Ravichandran V, Rhee WJ, Lee M, Ko YT, Shim MS. Bioreducible exosomes encapsulating Glycolysis inhibitors potentiate mitochondria-targeted sonodynamic most cancers remedy through cancer-targeted drug launch and mobile power depletion. Biomaterials. 2023;301:122242.
Solar R, Xiang J, Zhou Q, Piao Y, Tang J, Shao S, Zhou Z, Bae YH, Shen Y. The tumor EPR impact for most cancers drug supply: present standing, limitations, and alternate options. Adv Drug Deliv Rev. 2022;191:114614.
Dutta B, Barick KC, Hassan PA. Latest advances in lively focusing on of nanomaterials for anticancer drug supply. Adv Colloid Interface Sci. 2021;296:102509.
Ganta S, Devalapally H, Shahiwala A, Amiji M. A evaluation of stimuli-responsive nanocarriers for drug and gene supply. J Managed Launch. 2008;126:187–204.
Valgimigli L. Lipid peroxidation and antioxidant safety. Biomolecules 13 (2023).
Yoo JW, Irvine DJ, Discher DE, Mitragotri S. Bio-inspired, bioengineered and biomimetic drug supply carriers, nature critiques. Drug Discovery. 2011;10:521–35.
Ou YH, Liang J, Czarny B, Wacker MG, Yu V, Wang JW, Pastorin G. Extracellular vesicle (EV) biohybrid methods for most cancers remedy: current advances and future views. Sem Most cancers Biol. 2021;74:45–61.
Raposo G, Stahl PD. Extracellular vesicles: a brand new communication paradigm? Nat Rev Mol Cell Biol. 2019;20:509–10.
Huyan T, Li H, Peng H, Chen J, Yang R, Zhang W, Li Q. Extracellular Vesicles – Superior nanocarriers in Most cancers remedy: progress and achievements. Int J Nanomed. 2020;15:6485–502.
Tan J, Zhu C, Li L, Wang J, Xia XH, Wang C. Engineering cell membranes: from extraction methods to rising biosensing purposes. Anal Chem. 2024;96:7880–94.
Zhang X, Ma G, Wei W. Simulation of nanoparticles interacting with a cell membrane: probing the structural foundation and potential biomedical utility. NPG Asia Mater. 2021;13:52.
Balog S, de Almeida MS, Taladriz-Blanco P, Rothen-Rutishauser B, Petri-Fink A. Does the floor cost of the nanoparticles drive nanoparticle-cell membrane interactions? Curr Opin Biotechnol. 2024;87:103128.
Liu L, Bai X, Martikainen M-V, Kårlund A, Roponen M, Xu W, Hu G, Tasciotti E, Lehto V-P. Cell membrane coating integrity impacts the internalization mechanism of biomimetic nanoparticles. Nat Commun. 2021;12:5726.
Yang CH, Xue YX, Duan Y, Mao C, Wan MM. Extracellular vesicles and their engineering methods, supply methods, and biomedical purposes. J Managed Launch. 2024;365:1089–123.
Nizamudeen ZA, Xerri R, Parmenter C, Suain Okay, Markus R, Chakrabarti L, Sottile V. Low-Energy Sonication Can Alter Extracellular Vesicle Measurement and Properties, Cells 10 (2021).
Colja S, Jovcevska I, Samec N, Romih R, Zottel A. Sonication is an acceptable methodology for loading nanobody into glioblastoma small extracellular vesicles. Heliyon 9 (2023).
Pan YG, Wang F, Liu YH, Jiang JG, Yang YG, Wang HD. Learning the mechanism of CD47-SIRPα interactions on pink blood cells by single molecule pressure spectroscopy. Nanoscale. 2014;6:9951–4.
Oldenborg P.A., Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Function of CD47 as a marker of self on pink blood cells. Sci (New York N Y). 2000;288:2051–.
Waeterschoot J, Gosselé W, Lemež Š. Casadevall i solvas, synthetic cells for in vivo biomedical purposes by pink blood cell biomimicry. Nat Commun. 2024;15:2504.
Nandi A, Yan LJ, Jana CK, Das N. Function of catalase in oxidative Stress- and Age-Related degenerative ailments, oxidative medication and mobile longevity 2019 (2019) 9613090.
Baker A, Lin C-C, Lett C, Karpinska B, Wright MH, Lobby CH. Catalase: A important node within the regulation of cell destiny. Free Radic Biol Med. 2023;199:56–66.
Nguyen PHD, Jayasinghe MK, Le AH, Peng B, Le MTN. Advances in drug supply methods based mostly on pink blood cells and their Membrane-Derived nanoparticles. ACS Nano. 2023;17:5187–210.
Wang DD, Yao YZ, Xiao Y, Chen X, Hu J, Yang XL. Ultrasound responsive erythrocyte membrane-derived hybrid nanovesicles with managed drug launch for tumor remedy. Nanoscale. 2021;13:9945–51.
Zheng LT, Qin SS, Si W, Wang AQ, Xing BC, Gao RR, Ren XW, Wang L, Wu XJ, Zhang J, Wu N, Zhang N, Zheng H, Ouyang HQ, Chen KY, Bu ZD, Hu XD, Ji JF, Zhang ZM. Pan-cancer single cell panorama of tumor-infiltrating T cells, Science (New York, N.Y.) 374 (2021) 1462–.
Aktas ON, Öztürk AB, Erman B, Erus S, Tanju S, Dilege S. Function of pure killer cells in lung most cancers. J Most cancers Res Clin Oncol. 2018;144:997–1003.
Malmberg KJ, Carlsten M, Björklund A, Sohlberg E, Bryceson YT, Ljunggren HG. Pure killer cell-mediated immunosurveillance of human most cancers. Semin Immunol. 2017;31:20–9.
Cachot A, Bilous M, Liu YC, Li XK, Saillard M, Cenerenti M, Rockinger GA, Wyss T, Guillaume P, Schmidt J, Genolet R, Ercolano G, Protti MP, Reith W, Ioannidou Okay, de Leval L, Trapani JA, Coukos G, Harari A, Speiser DE, Mathis A, Gfeller D, Altug H, Romero P, Jandus C. Tumor-specific cytolytic CD4 T cells mediate immunity in opposition to human most cancers. Sci Adv 7 (2021).
Poh AR, Ernst M. Focusing on macrophages in most cancers: from bench to bedside. Entrance Oncol 8 (2018).
Zhu L, Yu X, Cao T, Deng H, Tang X, Lin Q, Zhou Q. Immune cell membrane-based biomimetic nanomedicine for treating most cancers metastasis. Acta Pharm Sin B. 2023;13:2464–82.
Xie F, Liu Z, Wang P, Cai M, Li Y, Yan J, Lin Q, Luo F. Self-Delivering nanodrugs developed through Small-Molecule-Directed meeting and macrophage cloaking for Sonodynamic-Augmented immunotherapy. Adv Healthc Mater. 2022;11:e2102770.
Li S, Lu Z, Wu S, Chu T, Li B, Qi F, Zhao Y, Nie G. The dynamic function of platelets in most cancers development and their therapeutic implications, nature critiques. Most cancers. 2024;24:72–87.
Jiang Y, Liao XM, Tang W, Huang CY, Pan Y, Ning SP. Platelet membrane biomimetic manganese carbonate nanoparticles promote breast Most cancers stem cell clearance for sensitized radiotherapy. Int J Nanomed. 2024;19:1699–707.
Schürch CM, Forster S, Brühl F, Yang SH, Felley-Bosco E, Hewer E. The don’t eat me sign CD47 is a novel diagnostic biomarker and potential therapeutic goal for diffuse malignant mesothelioma. Oncoimmunology. 2017;7:e1373235.
Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV, Carpenter C, Ramesh M, Qu V, Patel SH, Zhu J, Shi W, Hofman FM, Chen TC, Gao W, Zhang Okay, Chien S, Zhang L. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526:118–21.
Begley DJ. Understanding and circumventing the blood-brain barrier. Acta Paediatr. 2003;92:83–91.
van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. Overcoming the blood-brain tumor barrier for efficient glioblastoma therapy. Drug Resist Updates. 2015;19:1–12.
Nagy Z, Peters H, Huttner I. Fracture faces of cell junctions in cerebral endothelium throughout regular and hyperosmotic situations. Lab Make investments. 1984;50:313–22.
Burgess A, Hynynen Okay. Noninvasive and focused drug supply to the mind utilizing targeted ultrasound. ACS Chem Neurosci. 2013;4:519–26.
Mesiwala AH, Farrell L, Wenzel HJ, Silbergeld DL, Crum LA, Winn HR, Mourad PD. Excessive-intensity targeted ultrasound selectively disrupts the blood-brain barrier < i > in vivo. Ultrasound Med Biol. 2002;28:389–400.
Charabati M, Rabanel JM, Ramassamy C, Prat A. Overcoming the mind limitations: from immune cells to nanoparticles. Traits Pharmacol Sci. 2020;41:42–54.
Zhu JY, Zheng DW, Zhang MK, Yu WY, Qiu WX, Hu JJ, Feng J, Zhang XZ. Preferential Most cancers cell Self-Recognition and tumor Self-Focusing on by coating nanoparticles with homotypic Most cancers cell membranes. Nano Lett. 2016;16:5895–901.
Harris JC, Scully MA, Day ES. Most cancers cell Membrane-Coated nanoparticles for Most cancers administration. Cancers (Basel) 11 (2019).
Solar HP, Su JH, Meng QS, Yin Q, Chen LL, Gu WW, Zhang PC, Zhang ZW, Yu HJ, Wang SL, Li YP. Most cancers-Cell-Biomimetic nanoparticles for focused remedy of homotypic tumors. Adv Mater. 2016;28:9581–.
Zhan GT, Xu QB, Zhang ZL, Wei ZH, Yong TY, Bie NN, Zhang XQ, Li X, Li JY, Gan L, Yang XL. Biomimetic sonodynamic therapy-nanovaccine integration platform potentiates Anti-PD-1 remedy in hypoxic tumors. Nano Immediately 38 (2021).
Zhang LS, Yin T, Zhang BZ, Yan C, Lu CY, Liu LL, Chen Z, Ran H, Shi QX, Pan H, Ma AQ, Cai LT. Most cancers-macrophage hybrid membrane-camouflaged photochlor for enhanced sonodynamic remedy in opposition to triple-negative breast most cancers. Nano Res. 2022;15:4224–32.
Yu Y, Peng Y, Shen WT, Zhou Z, Kai M, Gao W, Zhang L. Hybrid cell Membrane-Coated nanoparticles for biomedical purposes. Small Struct 5 (2024).
Cai JL, Hu GP, Hu LH, Chen J, Chen D, Liu D, Wang XL, Hu BX, Li C. A CaCO3-based nanoplatform with sonodynamic and tumor microenvironment activated for mixed in vitro most cancers remedy. Translational Oncol 38 (2023).
Zhao H, Zhao B, Li L, Ding Okay, Xiao H, Zheng C, Solar L, Zhang Z, Wang L. Biomimetic decoy inhibits tumor development and lung metastasis by reversing the drawbacks of sonodynamic remedy. Adv Healthc Mater. 2020;9:e1901335.
Li Y, Liu Y, Xu J, Chen D, Wu T, Cao Y. Macrophage-Most cancers hybrid Membrane-Camouflaged nanoplatforms for HIF-1α gene Silencing-Enhanced sonodynamic remedy of glioblastoma. ACS Appl Mater Interfaces. 2023;15:31150–8.
Powell DR, Huttenlocher A. Neutrophils within the tumor microenvironment. Traits Immunol. 2016;37:41–52.
Campregher C, Luciani MG, Gasche C. Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells. Intestine. 2008;57:780–7.
Buitrago D, Keutgen XM, Crowley M, Filicori F, Aldailami H, Hoda R, Liu YF, Hoda RS, Scognamiglio T, Jin M, Fahey TJ, Zarnegar R. Intercellular adhesion Molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma. Ann Surg Oncol. 2012;19:973–80.
Sanchez-Rovira P, Jimenez E, Carracedo J, Barneto IC, Ramirez R, Aranda E. Serum ranges of intercellular adhesion molecule 1 (ICAM-1) in sufferers with colorectal most cancers: inhibitory impact on cytotoxicity, European journal of most cancers (Oxford, England: 1990) 34(1998):394–398.
Zhang R-Y, Cheng Okay, Solar X, Yang X-Q, Li Y, Hu Y-G, Zhang X-S, Liu B, Chen W, Zhao Y-D, Huang D-S. Biomimetic O2 Self-generated hybrid membrane nanoplatform for blocking the polarization in direction of immunosuppressive M2 macrophage phenotype and enhancing sonodynamics remedy in orthotopic colorectal most cancers. Chem Eng J. 2022;450:138337.
Stavrou A, Ortiz A. Extracellular vesicles: A novel instrument in nanomedicine and Most cancers therapy. Cancers 14 (2022).
Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M. A complete overview of exosomes as drug supply automobiles – Endogenous nanocarriers for focused most cancers remedy. Biochim Et Biophys Acta-Opinions Most cancers. 2014;1846:75–87.
Nowak M, Gorczynska J, Kolodzinska Okay, Rubin J, Choromanska A. Extracellular vesicles as drug transporters. Int J Mol Sci 24 (2023).
Zhang J, Tune HJ, Dong YA, Li GH, Li J, Cai QZ, Yuan SJ, Wang Y, Tune HF. Floor engineering of HEK293 Cell-Derived extracellular vesicles for improved Pharmacokinetic profile and focused supply of IL-12 for the therapy of hepatocellular carcinoma. Int J Nanomed. 2023;18:209–23.
Meng WR, He CS, Hao YY, Wang LL, Li L, Zhu GQ. Prospects and challenges of extracellular vesicle-based drug supply system: contemplating cell supply. Drug Supply. 2020;27:585–98.
Cheng HY, Wang ZC, Fu L, Xu TM. Macrophage polarization within the improvement and development of ovarian cancers: an outline. Entrance Oncol 9 (2019).
Mehla Okay, Singh PK. Metabolic regulation of macrophage polarization in Most cancers. Traits Most cancers. 2019;5:822–34.
Shao YC, Han S, Hou ZX, Yang C, Zhao YB. Tumor-associated macrophages inside the immunological milieu: an rising focus for therapeutic intervention. Heliyon 10 (2024).
Chen SJ, Wang JH, Liao HQ, Tang Okay, Xu Y, Wang L, Niu CC. M1 Macrophage-Derived sonoresponsive nanoparticles for sonodynamic anticancer remedy. Int J Nanomed. 2022;17:4725–41.
Liang YJ, Duan L, Lu JP, Xia J. Engineering exosomes for focused drug supply. Theranostics. 2021;11:3183–95.
Cao TGN, Hoang QT, Kang JH, Kang SJ, Ravichandran V, Rhee WJ, Lee M, Ko YT, Shim MS. Bioreducible exosomes encapsulating Glycolysis inhibitors potentiate mitochondria-targeted sonodynamic most cancers remedy through cancer-targeted drug launch and mobile power depletion. Biomaterials 301 (2023).
Naskar A, Cho H, Lee S, Kim KS. Biomimetic nanoparticles coated with bacterial outer membrane vesicles as a New-Technology platform for biomedical purposes. Pharmaceutics 13 (2021).
Zhang ZW, Tu JW, Kuang XF, Shi MY, Zhang YM, Li H, Huang JS, Wang L, Yuan HF. Bacterial outer membrane vesicle-modified metal-organic frameworks for sonodynamic therapy-immunotherapy of breast most cancers. New J Chem. 2023;48:367–76.
Ellis TN, Kuehn MJ. Virulence and Immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74:81–94.
Johnston EL, Zavan L, Bitto NJ, Petrovski S, Hill AF, Kaparakis-Liaskos M. Planktonic and Biofilm-Derived Pseudomonas aeruginosa outer membrane vesicles facilitate horizontal gene switch of plasmid DNA. Microbiol Spectr. 2023;11:e05179–05122.
Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from Gram-negative micro organism: biogenesis and features. Nat Rev Microbiol. 2015;13:605–19.
Wang JH, Liang SL, Chen SJ, Ma TL, Chen MY, Niu CC, Leng Y, Wang L. Bacterial outer membrane vesicle-cancer cell hybrid membrane-coated nanoparticles for sonodynamic remedy within the therapy of breast most cancers bone metastasis. J Nanobiotechnol 22 (2024).
Chen X, Li P, Luo B, Tune C, Wu M, Yao Y, Wang D, Li X, Hu B, He S, Zhao Y, Wang C, Yang X, Hu J. Floor mineralization of engineered bacterial outer membrane vesicles to reinforce tumor photothermal/immunotherapy. ACS Nano. 2024;18:1357–70.
Bussard KM, Mutkus L, Stumpf Okay, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Most cancers Res 18 (2016).
Valkenburg KC, de Groot AE, Pienta KJ. Focusing on the tumour stroma to enhance most cancers remedy. Nat Opinions Clin Oncol. 2018;15:366–81.
Liao CH, Liu XJ, Zhang C, Zhang Q. Tumor hypoxia: from primary information to therapeutic implications. Sem Most cancers Biol. 2023;88:172–86.
Belisario DC, Kopecka J, Pasino M, Akman M, De Smaele E, Donadelli M, Riganti C. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance, Cells 9 (2020).
Jägers J, Wrobeln A, Ferenz KB. Perfluorocarbon-based oxygen carriers: from physics to physiology. Pflugers Archiv-European J Physiol. 2021;473:139–50.
Wang B, Zhao Q, Zhang YY, Liu ZJ, Zheng ZZ, Liu SY, Meng LB, Xin Y, Jiang X. Focusing on hypoxia within the tumor microenvironment: a possible technique to enhance most cancers immunotherapy. J Experimental Clin Most cancers Res 40 (2021).
Yang Y, Liu Y, Jiang Y. Latest advances in Perfluorocarbon-Based mostly supply methods for Most cancers theranostics. Mol Pharm. 2023;20:3254–77.
Charbe NB, Castillo F, Tambuwala MM, Prasher P, Chellappan DK, Carreño A, Satija S, Singh SK, Gulati M, Dua Okay, González-Aramundiz JV, Zacconi FC. A brand new period in oxygen therapeutics? From perfluorocarbon methods to haemoglobin-based oxygen carriers. Blood Rev. 2022;54:100927.
Zhou A, Fang T, Chen Okay, Xu Y, Chen Z, Ning X. Biomimetic activator of sonodynamic ferroptosis amplifies inherent peroxidation for enhancing the therapy of breast most cancers, small (Weinheim an der Bergstrasse. Germany). 2022;18:e2106568.
Chen Q, Espey MG, Solar AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, Levine M. Ascorbate in Pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A. 2007;104:8749–54.
Kong H, Fang C, Chu Q, Hu Z, Fu Y, Han G, Li X, Zhou Y. Catalytic core-shell nanoparticles with self-supplied calcium and H(2)O(2) to allow combinational tumor Inhibition. J Nanobiotechnol. 2021;19:313.
Zhen C, Li J, Liu J, Lyu Y, Xie L, Lv H. Phenethyl isothiocyanate induces oxidative cell demise in osteosarcoma cells with regulation on mitochondrial community, perform and metabolism, biochimica et biophysica acta. Mol Foundation Illness. 2023;1869:166740.
Bao Y, Chen J, Qiu H, Zhang C, Huang P, Mao Z, Tong W. Erythrocyte Membrane-Camouflaged PCN-224 nanocarriers built-in with platinum nanoparticles and glucose oxidase for enhanced tumor sonodynamic remedy and synergistic hunger remedy. ACS Appl Mater Interfaces. 2021;13:24532–42.
Gao C, Kwong CHT, Wang Q, Kam H, Xie B, Lee SM, Chen G, Wang R. Conjugation of Macrophage-Mimetic microalgae and liposome for antitumor sonodynamic immunotherapy through hypoxia alleviation and autophagy Inhibition. ACS Nano. 2023;17:4034–49.
Li Q, Lin B, Li Y, Lu N. Erythrocyte-Camouflaged mesoporous titanium dioxide nanoplatform for an Ultrasound-Mediated sequential therapies of breast Most cancers. Int J Nanomed. 2021;16:3875–87.
Guo W, Wang T, Huang C, Ning S, Guo Q, Zhang W, Yang H, Zhu D, Huang Q-Q, Qian H, Wang X. Platelet membrane-coated C-TiO 2 Hole nanospheres for mixed sonodynamic and alkyl-radical most cancers remedy. Nano Res 16 (2022).
Albanese A, Daly LA, Mennerich D, Kietzmann T, Sée V. The function of Hypoxia-Inducible issue Submit-Translational modifications in regulating its localisation, stability, and exercise. Int J Mol Sci 22 (2020).
Liao C, Zhang Q. Understanding the Oxygen-Sensing pathway and its therapeutic implications in ailments. Am J Pathol. 2020;190:1584–95.
Zou W, Shah YM. A PHD in immunosuppression: oxygen-sensing pathways regulate immunosuppressive Tregs. J Clin Investig. 2019;129:3524–6.
Taylor CT. Mitochondria and mobile oxygen sensing within the HIF pathway. Biochem J. 2008;409:19–26.
Corbet C, Feron O. Tumour acidosis: from the passenger to the motive force’s seat, nature critiques. Most cancers. 2017;17:577–93.
Pillai SR, Damaghi M, Marunaka Y, Spugnini EP, Fais S, Gillies RJ. Causes, penalties, and remedy of tumors acidosis. Most cancers Metastasis Rev. 2019;38:205–22.
Rostamian H, Khakpoor-Koosheh M, Jafarzadeh L, Masoumi E, Fallah-Mehrjardi Okay, Tavassolifar MJ, J MP, Mirzaei HR, Hadjati J. Limiting tumor lactic acid metabolism utilizing Dichloroacetate improves T cell features. BMC Most cancers. 2022;22:39.
Li Y, Huang C, Xu Y. Colon most cancers exosome-derived biomimetic nanoplatform for curcumin-mediated sonodynamic remedy and calcium overload. Entrance Bioeng Biotechnol. 2022;10:1069676.
Chen Y, Ding T, Qian ZZ, Ma ZR, Zhou LM, Li ZL, Lv RK, Xu YH, Xu YJ, Hao LH, Zhu C, Yao XK, Yu WY, Fan WP. Biodegradable persistent ROS-generating nanosonosensitizers for enhanced synergistic most cancers remedy by inducing cascaded oxidative stress. Nanoscale Horizons. 2024;9:2306–19.
Chen X, Zhang H, Zhang M, Zhao P, Tune R, Gong T, Liu Y, He X, Zhao Okay, Bu W. Amorphous Fe-Based mostly nanoagents for Self‐Enhanced chemodynamic remedy by Re‐Establishing tumor acidosis. Adv Funct Mater. 2019;30:1908365.
Andreucci E, Peppicelli S, Ruzzolini J, Bianchini F, Calorini L. Physicochemical points of the tumour microenvironment as drivers of vasculogenic mimicry. Most cancers Metastasis Rev. 2022;41:935–51.
Han X, Zhou C, Luo X, Pang H, Han C, Tang L, Yang Z, Nong Y, Lu C. Tumor focusing on with Apatinib-loaded nanoparticles and sonodynamic mixed remedy. Curr Mol Med. 2024;24:648–66.
Feng Q, Yang X, Hao Y, Wang N, Feng X, Hou L, Zhang Z. Most cancers Cell Membrane-Biomimetic Nanoplatform for Enhanced Sonodynamic Remedy on Breast Most cancers through Autophagy Regulation Technique, ACS utilized supplies & interfaces 11 (2019) 32729–32738.
Glorieux C, Liu S, Trachootham D, Huang P. Focusing on ROS in most cancers: rationale and techniques, nature critiques. Drug Discovery. 2024;23:583–606.
Hecht F, Zocchi M, Alimohammadi F, Harris IS. Regulation of antioxidants in most cancers. Mol Cell. 2024;84:23–33.
Huang C, Ding S, Jiang W, Wang FB. Glutathione-depleting nanoplatelets for enhanced sonodynamic most cancers remedy. Nanoscale. 2021;13:4512–8.
Fan Y, Xu P, Fang Q, Zhu Y, Cao F, Zhao Z, Wu D, Yang X, Li D, Liu X. Biomimetic nanoparticle with glutathione depletion and amplified ROS era capabilities for synergistic Chemo-Sonodynamic remedy in squamous cell carcinomas. ACS Appl Mater Interfaces. 2023;15:27183–94.
Zhou L, Feng W, Mao Y, Chen Y, Zhang X. Nanoengineered sonosensitive platelets for synergistically augmented sonodynamic tumor remedy by glutamine deprivation and cascading thrombosis. Bioact Mater. 2023;24:26–36.
Cai J, Hu G, Hu L, Chen J, Chen D, Liu D, Wang X, Hu B, Li C. A CaCO(3)-based nanoplatform with sonodynamic and tumor microenvironment activated for mixed in vitro most cancers remedy. Transl Oncol. 2023;38:101771.
Piersma B, Hayward MK, Weaver VM. Fibrosis and most cancers: A strained relationship. Biochim Et Biophys Acta-Opinions Most cancers 1873 (2020).
Xu M, Zhang T, Xia R, Wei Y, Wei X. Focusing on the tumor stroma for most cancers remedy. Mol Most cancers. 2022;21:208.
Naber HPH, ten Dijke P, Pardali E. Function of TGF-β within the tumor stroma. Curr Most cancers Drug Targets. 2008;8:466–72.
Chen Z, Liu W, Yang Z, Luo Y, Qiao C, Xie A, Jia Q, Yang P, Wang Z, Zhang R. Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and rework tumor microenvironment for enhanced tumor immunotherapy. Theranostics. 2023;13:1571–83.
Xu S, Shi X, Ren E, Zhang J, Gao X, Mu D, Liu C, Liu G. Genetically engineered nanohyaluronidase vesicles: a sensible sonotheranostic platform for enhancing cargo penetration of stable tumors. Adv Funct Mater 32 (2022).
Xia AL, Zhang Y, Xu J, Yin TL, Lu XJ. T cell dysfunction in Most cancers immunity and immunotherapy. Entrance Immunol 10 (2019).
Solar C, Mezzadra R, Schumacher TN. Regulation and performance of the PD-L1 checkpoint. Immunity. 2018;48:434–52.
Chen L, Han X. Anti-PD-1/PD-L1 remedy of human most cancers: previous, current, and future. J Clin Investig. 2015;125:3384–91.
Wei X, Feng Z, Huang J, Xiang X, Du F, He C, Zhou M, Ma L, Cheng C, Qiu L. Homology and immune checkpoint dual-targeted sonocatalytic nanoagents for enhancing sonodynamic tumor remedy. ACS Appl Mater Interfaces. 2021;13:32810–22.
Wang HP, Yang F, Li YX, Zhang S, Shang JT, Hou XY, Tong YM, Zhou KY, Shu XJ, Solar BL, Lu CH, Liu YC. Cell Membrane-Liposome hybrid platform for Ultrasound-Activated Immune-Sonodynamic remedy for Triple-Damaging breast Most cancers. Acs Appl Nano Mater. 2023;6:16453–64.
Shan TK, Wang WD, Fan MY, Bi JJ, He TF, Solar YJ, Zheng M, Yan DM. Efficient glioblastoma immune sonodynamic therapy mediated by macrophage cell membrane cloaked biomimetic nanomedicines. J Managed Launch. 2024;370:866–78.
Zhan G, Xu Q, Zhang Z, Wei Z, Yong T, Bie N, Zhang X, Li X, Li J, Gan L, Yang X. Biomimetic sonodynamic therapy-nanovaccine integration platform potentiates Anti-PD-1 remedy in hypoxic tumors. Nano Immediately. 2021;38:101195.
Zhang L, Kang X, Wang T, Yu X, Liang M, Jiang J, Qi J, Li W. NO-Enhanced sonodynamic nanovesicles with Co-Stimulatory molecule Self-Presentation for multidimensional tumor immunotherapy. Angew Chem Int Ed Engl (2025) e202504684.
Lu Z, Bai S, Jiang Y, Wu S, Xu D, Zhang J, Peng X, Zhang H, Shi Y, Liu G. Amplifying dendritic cell activation by bioinspired nanometal natural frameworks for synergistic sonoimmunotherapy, small (Weinheim an der Bergstrasse. Germany). 2022;18:e2203952.
Liu XJ, Wu X, Wang YM, Li YH, Chen XL, Yang WC, Jiang LH. CD47 promotes human glioblastoma invasion by activation of the PI3K/Akt pathway. Oncol Res. 2019;27:415–22.
Hu T, Liu HS, Liang ZX, Wang FW, Zhou C, Zheng XB, Zhang YF, Tune YW, Hu JC, He XW, Xiao J, King RY, Wu XR, Lan P. Tumor-intrinsic CD47 sign regulates Glycolysis and promotes colorectal most cancers cell development and metastasis. Theranostics. 2020;10:4056–72.
Huang YT, Ma YC, Gao P, Yao Z. Focusing on CD47: the achievements and considerations of present research on most cancers immunotherapy. J Thorac Illness. 2017;9:E168–74.
Gong M, Huang Y, Feng H, Lin J, Huang A, Hu J, Tang Q, Zhu X, Han S, Lu J, Wang J. A nanodrug combining CD47 and sonodynamic remedy effectively inhibits osteosarcoma deterioration. J Managed Launch: Official J Managed Launch Soc. 2023;355:68–84.
Xie F, Liu Z, Wang P, Cai M, Li Y, Yan J, Lin Q, Luo F. Self-Delivering nanodrugs developed through Small-Molecule-Directed meeting and macrophage cloaking for Sonodynamic-Augmented immunotherapy. Adv Healthc Mater. 2022;11:e2202115.
Xing Y, Zhang F, Ji P, Wei M, Yin C, Yang A, Yang G, Zhao J. Environment friendly supply of GSDMD-N mRNA by engineered extracellular vesicles induces pyroptosis for enhanced immunotherapy, small (Weinheim an der Bergstrasse. Germany). 2023;19:e2204031.
Tan S, Li D, Zhu X. Most cancers immunotherapy: professionals, cons and past. Biomed Pharmacother. 2020;124:109821.
Chen Okay, Zhou A, Zhou X, Liu Y, Xu Y, Ning X. An clever Cell-Derived nanorobot bridges synergistic crosstalk between sonodynamic remedy and Cuproptosis to advertise Most cancers therapy. Nano Lett. 2023;23:3038–47.
Guo W, Wang T, Huang C, Ning S, Guo Q, Zhang W, Yang H, Zhu D, Huang Q, Qian H, Wang X. Platelet membrane-coated C-TiO2 Hole nanospheres for mixed sonodynamic and alkyl-radical most cancers remedy. Nano Res. 2023;16:782–91.
Gao C, Kwong CHT, Wang Q, Kam H, Xie B, Lee SM-Y, Chen G, Wang R. Conjugation of Macrophage-Mimetic microalgae and liposome for antitumor sonodynamic immunotherapy through hypoxia alleviation and autophagy Inhibition. ACS Nano. 2023;17:4034–49.